Neglected tropical diseases<\/b>\u00a0(NTDs<\/b>) are a diverse group of\u00a0tropical infections<\/a>\u00a0that are common in low-income populations in\u00a0developing regions<\/a>\u00a0of\u00a0Africa<\/a>,\u00a0Asia<\/a>, and the\u00a0Americas<\/a>. They are caused by a variety of pathogens, such as\u00a0viruses<\/a>,\u00a0bacteria<\/a>,\u00a0protozoa<\/a>,\u00a0and parasitic worms (helminths<\/a>). These diseases are contrasted with the “big three” infectious diseases (HIV\/AIDS<\/a>,\u00a0tuberculosis<\/a>, and\u00a0malaria<\/a>), which generally receive greater treatment and research funding. In sub-Saharan Africa,\u00a0the effect<\/a>\u00a0of neglected tropical diseases as a group is comparable to that of malaria and tuberculosis. NTD co-infection can also make HIV\/AIDS and tuberculosis more deadly. Skin-related neglected tropical diseases, or \u201cskin NTDs\u201d, are historically neglected because active case detection, individual case management, significant resources, and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offer a pathway to overcoming some of these past challenges.<\/p>\n At least ten of the diseases included in WHO\u2019s list of NTDs present with changes on the skin before other changes occur in the internal organs or physical disabilities develop. Given this commonality and the likely co-endemicity of many of these diseases, WHO has created a\u00a0platform for skin NTDs to operationalize the cross-cutting approaches of the road map by integrating relevant activities as applicable. The skin NTDs include Buruli ulcer; cutaneous leishmaniasis; mycetoma, chromoblastomycosis and other deep mycoses; leprosy (Hansen\u2019s disease); lymphatic filariasis; onchocerciasis; post-kala-azar dermal leishmaniasis; scabies and other ectoparasitoses (including tungiasis); and yaws.<\/p>\n To measure progress against skin NTDs and integrated approaches for their control and management, countries are encouraged to adapt the road map\u2019s indicators and define milestones and targets to enable in-country control and management of skin NTDs. Integrated reporting of skin NTDs on a\u00a0common health information system will not only improve the cost\u2212effectiveness of monitoring and evaluation but also streamline the use of data for planning and action across all endemic skin NTDs.<\/p>\n Integrated active case detection, wound and lymphoedema management, training of health care workers in basic dermatology using skin NTD training materials, Apps and teledermatology are being practiced by some countries of different regions. These examples of good practices are drivers for other countries to implement integrated control and management of skin NTDs. Once this framework is adapted by countries in which skin NTDs are endemic, more evidence will be generated and reflected in future editions of this document.<\/p>\n A broad range of research is required to improve control of skin NTDs. Scientific understanding of each skin disease, point-of-care diagnostics and better medicines are needed. Operational research is also needed, for example, to evaluate training and training materials from which to improve integrated case detection on the front line of health care and to identify the roles of persons affected by skin NTDs and their families. Ideally, care should be provided close to where patients live. Given the growing availability of mobile phones and Internet connectivity, new technologies such as mHealth tools and teledermatology can be used. The recently established evidence for chemoprophylaxis supports use of targeted MDA against diseases such as scabies and yaws in areas of high endemicity. Strategies to control and manage skin NTDs are evolving with new knowledge and innovations.<\/p>\n","protected":false},"excerpt":{"rendered":"Skin NTDs<\/h3>\n
Implementation of the framework and evaluation of progress<\/h3>\n
Ongoing country experiences in\u00a0integration<\/h3>\n
Looking forward<\/h3>\n